WELLS FARGO & COMPANY/MN - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 132 filers reported holding WUXI PHARMATECH CAYMAN INC in Q3 2013. The put-call ratio across all filers is 0.04 and the average weighting 0.7%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$52,000
-70.9%
1,219
-71.1%
0.00%
Q2 2015$179,000
-97.4%
4,222
-97.7%
0.00%
-100.0%
Q1 2015$6,996,000
+127.7%
180,374
+97.7%
0.00%0.0%
Q4 2014$3,072,000
-18.4%
91,229
-15.1%
0.00%
-50.0%
Q3 2014$3,763,000
+9.8%
107,433
+3.0%
0.00%
+100.0%
Q2 2014$3,427,000
-21.0%
104,311
-11.4%
0.00%
-50.0%
Q1 2014$4,338,000
-14.6%
117,688
-11.1%
0.00%0.0%
Q4 2013$5,079,000
+48.8%
132,334
+6.2%
0.00%0.0%
Q3 2013$3,413,000
+18.2%
124,569
-9.4%
0.00%
+100.0%
Q2 2013$2,888,000137,5580.00%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q3 2013
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 449,361$15,737,00015.66%
Sloane Robinson LLP 120,000$4,202,0006.01%
Black Creek Investment Management Inc. 869,173$30,438,0003.50%
Grandeur Peak Global Advisors, LLC 358,385$12,551,0003.05%
THOMAS WHITE INTERNATIONAL LTD 538,212$18,848,0002.73%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 88,460$3,098,0001.39%
Granite Point Capital Management, L.P. 70,000$2,451,0001.22%
COMMONWEALTH BANK OF AUSTRALIA 2,626,749$91,989,0001.19%
Apex Capital Management 1,048,531$36,720,0001.11%
Pier Capital, LLC 196,369$6,877,0001.10%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders